| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 403,389 | 342,204 | 253,493 | 378,040 | | Cost of Revenue | 369,082 | 309,957 | 222,517 | 337,513 | | | Gross Profit | 34,307 | 32,247 | 30,976 | 40,527 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,128 | 8,306 | 8,754 | 9,055 | | Non Recurring | 158 | 60 | (218) | (7) | | Others | 15,806 | 16,133 | 15,419 | 19,760 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,356 | 7,748 | 7,021 | 11,719 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 159 | 16 | 21 | 106 | | Earnings Before Interest And Taxes | 7,586 | 8,028 | 8,948 | 11,956 | | Interest Expense | 3,436 | 3,389 | 3,056 | 4,852 | | Income Before Tax | 4,150 | 4,639 | 5,892 | 7,104 | | Income Tax Expense | 253 | 817 | 591 | 871 | | Minority Interest | 1,025 | 11 | (11) | 120 | | | | Net Income From Continuing Ops | 6,304 | 3,833 | 5,290 | 6,353 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,922 | 3,833 | 5,290 | 6,353 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,922 | $3,833 | $5,290 | $6,353 |
|
0.51% Nasdaq 
Income Statement
